Physicochemical characteristics and gastrointestinal absorption behaviors of S-propargyl-cysteine, a potential new drug candidate for cardiovascular protection and antitumor treatment

References

• Amidon GL, Lennernäs H, Shah VP, et al. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–20
   PubMed Web of Science ®Google Scholar
• Baka E, Comer JE, Takács-Novák K. (2008). Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal 46:335–41
   PubMed Web of Science ®Google Scholar
• Berggren S, Hoogstraate J, Fagerholm U, et al. (2004). Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models. Eur J Pharm Sci 21:553–60
   PubMed Web of Science ®Google Scholar
• Brendan G, Caitriona OD. (2008). Models of the small intestine. In: Ehrhardt C, Kim KJ, eds. Biotechnology: pharmaceutical aspects, vol VII. Drug absorption studies in situ, in vitro and in silico models. New York: Springer, 1–76
   Google Scholar
• Bröer S. (2008). Amino acid transport across mammalian intestinal and renal epithelia. Physiol Rev 88:249–86
   PubMed Web of Science ®Google Scholar
• Capasso A. (2013). Antioxidant action and therapeutic efficacy of Allium sativum L. Molecules 18:690–700
   PubMed Web of Science ®Google Scholar
• CDER/FDA. (2000). Guidance for industry, waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system. Washington, DC
   Google Scholar
• Chavda HV, Patel CN, Anand IS. (2010). Biopharmaceutics classification system. Syst Rev Pharm 1:62–9
   Google Scholar
• Chinese Pharmacopoeia Committee. (2010). Pharmacopoeia of the People’s Republic of China, vol. 2. Beijing: Chinese Medical Science Press
   Google Scholar
• Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMA). (2010). Guideline on the investigation of bioequivalence. Available from: http://www.ema.europa.eu/pdf/human/qwp/140198enrev1fin.pdf [last accessed 20 Aug 2014]
   Google Scholar
• Dahan A, Miller JM, Amidon GL. (2009). Prediction of solubility and permeability class membership: provisional BCS classification of the world’s top oral drugs. AAPS J 11:740–6
   PubMed Web of Science ®Google Scholar
• Dahan A, Miller JM, Hilfinger JM, et al. (2010). High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations. Mol Pharm 7:1827–34
   PubMed Web of Science ®Google Scholar
• Dressman JB, Lennernas H. (2000). Oral drug absorption: prediction and assessment. New York: Marcel Dekker Inc
   Google Scholar
• Fagerholm U, Johansson M, Lennernäs H. (1996). Comparison between permeability coefficients in rat and human jejunum. Pharm Res 13:1336–42
   PubMed Web of Science ®Google Scholar
• Gong QH, Pan LL, Liu XH, et al. (2011a). S-propargyl-cysteine (ZYZ-802), a sulphur-containing amino acid, attenuates beta-amyloid-induced cognitive deficits and pro-inflammatory response: involvement of ERK1/2 and NF-κB pathway in rats. Amino Acids 40:601–10
   PubMed Web of Science ®Google Scholar
• Gong QH, Wang Q, Pan LL, et al. (2011b). S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: involvement of TNF signaling and NF-κB pathway in rats. Brain Behav Immun 25:110–19
   PubMed Web of Science ®Google Scholar
• Ho NF, Park JY, Morozowich W, et al. (1977). Physical model approach to the design of drugs with improved intestinal absorption. In: Roche EB, ed. Design of biopharmaceutical properties through prodrugs and analogs, vol. 8. Washington, DC: AAPS, 136–227
   Google Scholar
• Holmstock N, Annaert P, Augustijns P. (2012). Boosting of HIV protease inhibitors by ritonavir in the intestine: the relative role of cytochrome P450 and P-glycoprotein inhibition based on Caco-2 monolayers versus in situ intestinal perfusion in mice. Drug Metab Dispos 40:1473–7
   PubMed Web of Science ®Google Scholar
• Hu M, Li XL. (2011). Oral bioavailability: basic principles, advanced concepts, and applications. Hoboken (NJ): Wiley
   Google Scholar
• Huang C, Kan J, Liu X, et al. (2013). Cardioprotective effects of a novel hydrogen sulfide agent-controlled release formulation of s-propargyl-cysteine on heart failure rats and molecular mechanisms. PLoS One 8:e69205
   PubMed Web of Science ®Google Scholar
• Iciek M, Kwiecień I, Włodek L. (2009). Biological properties of garlic and garlic-derived organosulfur compounds. Environ Mol Mutagen 50:247–65
   PubMed Web of Science ®Google Scholar
• Kan J, Guo W, Huang C, et al. (2014). S-propargyl-cysteine, a novel water-soluble modulator of endogenous hydrogen sulfide, promotes angiogenesis through activation of signal transducer and activator of transcription 3. Antioxid Redox Signal 20:2303–16
   PubMed Web of Science ®Google Scholar
• Kim CS, Cho SH, Chun HS, et al. (2008). BCH, an inhibitor of system L amino acid transporters, induces apoptosis in cancer cells. Biol Pharm Bull 31:1096–100
   PubMed Web of Science ®Google Scholar
• Kodera Y, Suzuki A, Imada O, et al. (2002). Physical, chemical, and biological properties of S-allylcysteine, an amino acid derived from garlic. J Agric Food Chem 50:622–32
   PubMed Web of Science ®Google Scholar
• Leeson P. (2012). Drug discovery: chemical beauty contest. Nature 481:455–6
   PubMed Web of Science ®Google Scholar
• Lennernäs H. (1995). Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation? Pharm Res 12:1573–82
   Google Scholar
• Ling W, Rui LC, Hua JX. (2007). In situ intestinal absorption behaviors of tanshinone IIA from its inclusion complex with hydroxypropyl-beta-cyclodextrin. Biol Pharm Bull 30:1918–22
   PubMedGoogle Scholar
• Lipinski CA. (2002). Poor aqueous solubility-an industry wide problem in drug discovery. Am Pharm Rev 5:82–5
   Google Scholar
• Lipinski C. (2003). Estimation of solubility, permeability, absorption and bioavailability. In: van de Waterbeemd H, Lennernas H, Artursson P, eds. Drug bioavailability. Weinheim: Wiley-VCH Verlag GmbH, 215–31
   Google Scholar
• Lipinski CA. (2004). Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today: Technol 1:337–41
   PubMedGoogle Scholar
• Luo Z, Liu Y, Zhao B, et al. (2013). Ex vivo and in situ approaches used to study intestinal absorption. J Pharmacol Toxicol Methods 68:208–16
   PubMed Web of Science ®Google Scholar
• Ma K, Liu Y, Zhu Q, et al. (2011). H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? PLoS One 6:e2052
   Google Scholar
• Miller JM, Dahan A, Gupta D, et al. (2010). Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir. Mol Pharm 7:1223–34
   PubMed Web of Science ®Google Scholar
• Muñoz MJ, Merino-Sanjuán M, Lledó-García R, et al. (2005). Use of nonlinear mixed effect modeling for the intestinal absorption data: application to ritonavir in the rat. Eur J Pharm Biopharm 61:20–6
   PubMedGoogle Scholar
• Pan LL, Liu XH, Gong QH, et al. (2011). S-propargyl-cysteine (SPRC) attenuated lipopolysaccharide-induced inflammatory response in H9c2 cells involved in a hydrogen sulfide-dependent mechanism. Amino Acids 41:205–15
   PubMed Web of Science ®Google Scholar
• Rothwell JA, Day AJ, Morgan MR. (2005). Experimental determination of octanol-water partition coefficients of quercetin and related flavonoids. J Agric Food Chem 53:4355–60
   PubMed Web of Science ®Google Scholar
• Sangster J. (1997). Octanol-water partition coefficients: fundamentals and physical chemistry. Chichester: John Wiley & Sons Ltd
   Google Scholar
• Shore PA, Brodie BB, Hogben CA. (1957). The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther 119:361–9
   PubMed Web of Science ®Google Scholar
• Sidhapuriwala JN, Hegde A, Ang AD, et al. (2012). Effects of S-propargyl-cysteine (SPRC) in caerulein-induced acute pancreatitis in mice. PLoS One 7:e32574
   PubMed Web of Science ®Google Scholar
• Taiming L, Xuehua J. (2006). Investigation of the absorption mechanisms of baicalin and baicalein in rats. J Pharm Sci 95:1326–33
   PubMed Web of Science ®Google Scholar
• Tam KY, Avdeef A, Tsinman O, et al. (2010). The permeation of amphoteric drugs through artificial membranes-an in combo absorption model based on paracellular and transmembrane permeability. J Med Chem 53:392–401
   PubMedGoogle Scholar
• Varma MV, Gardner I, Steyn SJ, et al. (2012). pH-dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery. Mol Pharm 9:1199–212
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu HR, Mu Q, et al. (2009). S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway. J Cardiovasc Pharmacol 54:139–46
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang XL, Liu HR, et al. (2010). Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H2S production. Antioxid Redox Signal 12:1155–65
   PubMed Web of Science ®Google Scholar
• WHO Expert Committee on Specifications for Pharmaceutical Preparations Fortieth Report. (2013). Annex 8: proposal to waive in vivo bioequivalence requirements for WHO model list of essential medicines immediate release, solid oral dosage forms. Available from: http://whqlibdoc.who.int/trs/ WHO_TRS_937_eng.pdf [last accessed 20 Oct 2014]
   Google Scholar
• Zhang Y, Wang Y, Fang SN, et al. (2013). Determination of stability constant of neutral amino acid with Bjerrum’s Half-integer formation function method. J Anal Sci 29:113–16
   PubMedGoogle Scholar
• Zheng Y, Liu H, Ma G, et al. (2011). Determination of S-propargyl-cysteine in rat plasma by mixed-mode reversed-phase and cation-exchange HPLC–MS/MS method and its application to pharmacokinetic studies. J Pharm Biomed Anal 54:1187–97
   PubMed Web of Science ®Google Scholar
• Zheng Y, Xu J, Ma G, et al. (2012). Bioavailability and pharmacokinetics of S-propargyl-L-cysteine, a novel cardioprotective agent, after single and multiple doses in Beagle dogs. Xenobiotica 42:304–9
   PubMed Web of Science ®Google Scholar
• Zheng YQ, Qiu YH, Lu FMY, et al. (1999). Permeability and absorption of leuprolide from various intestinal regions in rabbits and rats. Int J Pharm 185:83–92
   PubMed Web of Science ®Google Scholar
• Zhou LP, Wang JL. (2008). Physico-chemical characterization in drug discovery. Trend Bio/Pharm Ind 4:12–18
   Google Scholar
• Zhu JB. (2011). Modern biopharmaceutics. Beijing: People’s Medical Publishing House
   Google Scholar